These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27234306)

  • 1. The ligand (s) anchored lipobrid nanoconstruct mediated delivery of methotrexate: an effective approach in breast cancer therapeutics.
    Garg NK; Singh B; Kushwah V; Tyagi RK; Sharma R; Jain S; Katare OP
    Nanomedicine; 2016 Oct; 12(7):2043-2060. PubMed ID: 27234306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics.
    Garg NK; Singh B; Jain A; Nirbhavane P; Sharma R; Tyagi RK; Kushwah V; Jain S; Katare OP
    Colloids Surf B Biointerfaces; 2016 Oct; 146():114-26. PubMed ID: 27268228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
    Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
    Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model.
    Zhuang YG; Xu B; Huang F; Wu JJ; Chen S
    Pharmazie; 2012 Nov; 67(11):925-9. PubMed ID: 23210242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
    Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
    Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreducible cross-linked core polymer micelles enhance in vitro activity of methotrexate in breast cancer cells.
    Gulfam M; Matini T; Monteiro PF; Riva R; Collins H; Spriggs K; Howdle SM; Jérôme C; Alexander C
    Biomater Sci; 2017 Feb; 5(3):532-550. PubMed ID: 28124699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer.
    Jain A; Sharma G; Kushwah V; Garg NK; Kesharwani P; Ghoshal G; Singh B; Shivhare US; Jain S; Katare OP
    Nanomedicine (Lond); 2017 Aug; 12(15):1851-1872. PubMed ID: 28703643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells.
    Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE
    Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
    Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D
    Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells.
    Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z
    J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative and apoptotic potential of methotrexate lipid nanoparticles in a murine breast cancer model.
    Surve C; Banerjee A; S A; Chakraborty R; Kumar D; Butti R; Gorain M; Parida S; Kundu GC; Shidhaye S; Patnaik S
    Nanomedicine (Lond); 2022 May; 17(11):753-764. PubMed ID: 35575008
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer.
    Yang M; Kim JS; Kim J; Jang S; Kim SH; Kim JC; Shin T; Wang H; Moon C
    Brain Res Bull; 2012 Oct; 89(1-2):50-6. PubMed ID: 22796103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of pH-sensitive lysozyme/pectin nanogel for tumor methotrexate delivery.
    Lin L; Xu W; Liang H; He L; Liu S; Li Y; Li B; Chen Y
    Colloids Surf B Biointerfaces; 2015 Feb; 126():459-66. PubMed ID: 25601095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.
    Dhanikula RS; Argaw A; Bouchard JF; Hildgen P
    Mol Pharm; 2008; 5(1):105-16. PubMed ID: 18171013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate-grafted-oligochitosan micelles as drug carriers: synthesis and biological evaluations.
    Fattahi A; Asgarshamsi M; Hasanzadeh F; Varshosaz J; Rostami M; Mirian M; Sadeghi-aliabadi H
    J Mater Sci Mater Med; 2015 Feb; 26(2):119. PubMed ID: 25677115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fullerenol-Based Intracellular Delivery of Methotrexate: A Water-Soluble Nanoconjugate for Enhanced Cytotoxicity and Improved Pharmacokinetics.
    Bahuguna S; Kumar M; Sharma G; Kumar R; Singh B; Raza K
    AAPS PharmSciTech; 2018 Apr; 19(3):1084-1092. PubMed ID: 29159749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of ultrafine gold nanoparticles (AuNPs) based nanoformulation as single conjugates target delivery for improved methotrexate chemotherapy in breast cancer.
    Naz F; Kumar Dinda A; Kumar A; Koul V
    Int J Pharm; 2019 Oct; 569():118561. PubMed ID: 31381989
    [No Abstract]   [Full Text] [Related]  

  • 18. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery.
    Kaasgaard T; Andresen TL; Jensen SS; Holte RO; Jensen LT; Jørgensen K
    Chem Phys Lipids; 2009 Feb; 157(2):94-103. PubMed ID: 19094974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines.
    Herman S; Zurgil N; Deutsch M
    Inflamm Res; 2005 Jul; 54(7):273-80. PubMed ID: 16134056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate-gelonin conjugate - an inhibitor of MCF-7 cells expressing the dihydrofolate receptor.
    Badr M; Kopp C; Theison S; Meyer J; Trommer WE
    Biol Chem; 2014 Dec; 395(12):1461-6. PubMed ID: 25205711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.